Chief Executive Officer
Dr. Khwaja has more than 20 years of experience in drug development and has been involved in drug repurposing research for a decade both in academic and industrial settings. She brings extensive international experiences to her position as Chief Executive Officer and has been a major factor in shaping Sarfez Pharmaceuticals as an up-and-coming pharmaceutical company. She has published extensively and has presented her work in both national and international venues. Fatima has a Ph.D. in molecular biology from Jawaharlal Nehru University, New Delhi and Post-Graduate Diploma in Marketing and Management from Indira Gandhi Open National University, New Delhi, India.
Back to top
Medical Affairs Advisor
Dr. Feig has spent more than 20 years in various executive roles in the pharmaceutical industry, most recently at Merck Research Laboratories, with responsibility for cardiovascular programs worldwide. As an executive in the pharmaceutical industry, Dr. Feig has taken several products from Phase I through marketing approval and has had key roles in worldwide in- and out-licensing and development of marketing strategies. Since 2008, Peter has been a faculty member of the Columbia University College of Physicians and Surgeons, an outpatient physician at Columbia Presbyterian Hospital and a teaching faculty member in the Nephrology Division. Peter trained as a Clinical Fellow (Nephrology) at Beth Israel Hospital, Boston, MA and as a Research Fellow at Harvard Medical School, Boston, MA. His therapeutic areas of expertise are cardiovascular and metabolic diseases. He has been the recipient of many public and private research grants and has authored or co-authored more than 90 original articles, reviews, book chapters and abstracts. Peter, a Board-certified internist and nephrologist, has an M.D. from University of Sao Paulo School of Medicine, Sao Paulo, Brazil.
Back to top